Pharma firm Biocon's Q4 net profits up 31 pc; announces dividend for investors

May 24, 2023

Global biopharmaceuticals company Biocon has announced its consolidated financial results for the fourth quarter and the fiscal year that ended on March 31, 2023.

Biocon Q2FY23 Revenue at Rs 2,384 Cr., Up 23 percent; Core EBITDA at Rs 816 Cr., Up 34 percent Gross R&D Spend at Rs 252 Crore, Up 52 percent

Nov 15, 2022

Bengaluru (Karnataka) [India], November 15 (ANI/NewsVoir): Biocon Ltd, an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the second quarter ended...

Biocon posts Rs 257 crore profit for Q4 on strong biosimilar business

Apr 29, 2021

Bengaluru (Karnataka) [India], April 29 : Biopharmaceuticals major Biocon Ltd on Thursday reported net profit of Rs 257 crore in the fourth quarter of...

Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI

Mar 18, 2022

New Delhi [India], March 18 : Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to...

DCGI gives emergency use authorisation to India's first mRNA COVID-19 vaccine: Sources

Jun 28, 2022

New Delhi [India], June 28 : The Drugs Controller General of India (DCGI) has approved two doses of Pune-based Gennova Biopharmaceuticals' mRNA COVID-19 vaccine...

PM Modi appreciates scientists' efforts to come out with vaccine solution to combat COVID-19

Nov 30, 2020

New Delhi [India], November 30 : Prime Minister Narendra Modi on Monday appreciated the efforts by scientists in Gennova Biopharmaceuticals Ltd, Biological E Ltd...